Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 3/20 | 0.69 |
| ▸ | ADRB3 | P13945 | 16/20 | 0.65 |
| ▸ | ADRB1 | P08588 | 12/20 | 0.65 |
| ▸ | ADRB2 | P07550 | 12/20 | 0.65 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.61 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.59 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7211873 | 1.00 | SLC2A1 (0.69) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL7148487 | 1.00 | SLC2A1 (0.69) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL7148491 | 1.00 | SLC2A1 (0.69) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL10838570 | 0.91 | SLC2A1 (0.67) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL10839684 | 0.90 | SLC2A1 (0.65) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| Bromide SCHEMBL10973917 | 0.89 | SLC2A1 (0.64) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL8974973 | 0.89 | SLC2A1 (0.60) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL7152931 | 0.87 | ADRB2 (0.53) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL7152935 | 0.87 | ADRB2 (0.53) | SLC2A1ADRB3ADRB1ADRB2GLA | |
| SCHEMBL7147388 | 0.87 | ADRB2 (0.52) | SLC2A1ADRB3ADRB1ADRB2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0455006-B1 | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles | AMERICAN CYANAMID CO (US) | 1999-07-07 | — | — | EP | disclosed |
| US-5373020-A | Antidiabetic, antiobesity, hyperglycemic agents | AMERICAN CYANAMID COMPANY (US) | 1994-12-13 | — | — | US | disclosed |
| US-5245053-A | Resolution of diastereoisomers, reaction with Mosher's acid hypoglycemic agent, diabetes | AMERICAN CYANAMID COMPANY (US) | 1993-09-14 | — | — | US | disclosed |
| US-5151439-A | Antidiabetic agents or antihyperglycemic agents | AMERICAN CYANAMID COMPANY (US) | 1992-09-29 | — | — | US | disclosed |
| EP-0455006-A2 | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles | AMERICAN CYANAMID COMPANY (US) | 1991-11-06 | — | — | EP | disclosed |
| US-5061727-A | ANTIOBESITY, ANTIDIABETIC, HYPOGLYCEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1991-10-29 | — | — | US | disclosed |